You have 9 free searches left this month | to do more

decitabine

Decitabine is a drug used to treat Acute Myeloid Leukemia, Myelodysplastic Syndrome, Myelodysplastic Syndromes, and other conditions. Decitabine is being actively studied in 81 studies and prior, has been studied in 92.

Top SponsorsTop SitesTop Investigators
M.D. Anderson Cancer CenterUniversity of Texas MD Anderson Cancer CenterHan weidong
National Cancer Institute (NCI)M D Anderson Cancer CenterQifa Liu
Eisai Inc.Roswell Park Cancer InstituteMing Hou
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Suspended
  • Acute Myeloid Leukemia
  • Decitabine
  • +2 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
2021-09-07
Sep 7, 2021
M
Not yet recruiting
  • Chronic Myelomonocytic Leukemia
  • +3 more
  • Decitabine
  • Tagraxofusp-erzs
  • Houston, Texas
    M D Anderson Cancer Center
2021-11-22
Nov 22, 2021
I
Recruiting
  • Refractory Aplastic Anemia
  • Decitabine
  • Tianjin, Tianjin, China
    Regenerative Medicine Center
2021-05-10
May 10, 2021
T
Withdrawn
  • Myelodysplastic Syndromes (MDS)
  • (no location specified)
2021-09-23
Sep 23, 2021
N
Active, not recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
2021-12-15
Dec 15, 2021
M
Active, not recruiting
  • Myelodysplastic Syndromes
  • decitabine
  • +6 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
2021-05-07
May 7, 2021
U
Active, not recruiting
  • Acute Myelogenous Leukemia
  • Decitabine
  • Rochester, New York
    University of Rochester
2021-12-08
Dec 8, 2021
V
Active, not recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Sarcoma
  • Iowa City, Iowa
    University of Iowa Hospitals and Clinics
2021-12-03
Dec 3, 2021
U
Not yet recruiting
  • PTCL
  • CTCL
  • (no location specified)
2021-09-28
Sep 28, 2021
B
Recruiting
  • Myelodysplastic Syndromes
  • MDS/MPN Crossover Syndromes
  • Cleveland, Ohio
    Cleveland Medical Center, University Hospitals Seidman Cancer Ce
2021-08-19
Aug 19, 2021
U
Active, not recruiting
  • Acute Myeloid Leukemia
  • Baltimore, Maryland
    University of Maryland Greenebaum Comprehensive Cancer Center
2021-10-05
Oct 5, 2021
U
Recruiting
  • Acute Myeloid Leukemia
  • Chicago, Illinois
    University Of Chicago Medicine Comprehensive Cancer Center
2021-05-12
May 12, 2021
F
Terminated
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Philadelphia, Pennsylvania
  • +1 more
2021-02-22
Feb 22, 2021
S
Completed
  • Response Rate
  • Decitabine
  • Shanghai, Shanghai, China
    Blood & Marrow Transplantation Center, RuiJin Hospital
2021-05-19
May 19, 2021
J
Recruiting
  • COVID-19
  • Decitabine
  • Placebo Saline
  • Baltimore, Maryland
    Johns Hopkins University
2021-09-27
Sep 27, 2021
C
Active, not recruiting
  • Acute Myeloid Leukemia
  • +5 more
  • Decitabine
  • +3 more
  • Duarte, California
    City of Hope Medical Center
2021-02-15
Feb 15, 2021
C
Recruiting
  • Acute Myeloid Leukemia
  • +7 more
  • Decitabine
  • Pembrolizumab
  • Duarte, California
    City of Hope Medical Center
2021-11-23
Nov 23, 2021
S
Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • STAT Inhibitor OPB-111077
  • +3 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
2021-06-08
Jun 8, 2021
T
Recruiting
  • Acute Myeloid Leukemia
  • Complex Karyotype
  • Decitabine
  • Hong Kong, Hong Kong
    The University of Hong Kong
2021-04-26
Apr 26, 2021
U
Recruiting
  • Acute Myeloid Leukemia
  • +8 more
  • Decitabine
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2021-08-27
Aug 27, 2021
M
Completed
  • Blasts More Than 20 Percent of Bone Marrow Nucleated Cells
  • +4 more
  • Decitabine
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
2021-03-19
Mar 19, 2021
R
Recruiting
  • P53 Mutation
  • +3 more
  • Decitabine
  • Arsenic Trioxide
  • Shanghai, Shanghai, China
    Hematological department, Shanghai Institute of Hematology, Ruij
2021-04-20
Apr 20, 2021
Y
Terminated
  • ACUTE MYELOID LEUKEMIA
  • New Haven, Connecticut
    Yale Cancer Center/Smilow
2021-09-18
Sep 18, 2021
W
Active, not recruiting
  • Acute Myeloid Leukemia
  • Acute Myeloid Leukemia, Relapsed, Adult
  • Decitabine
  • +4 more
  • Saint Louis, Missouri
    Washington University School of Medicine
2021-06-01
Jun 1, 2021